Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Medicines Co (MDCO)    
$24.43 0.20 (0.81%) as of 4:30 Fri 7/25


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 63,440,000 as of 12/25
Market Cap: 1.55(B)
Last Volume: 661,044 Avg Vol: 645,131
52 Week Range: $24.02 - $40.39
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Medicines is a biopharmaceutical company. Co. has four marketed products, Angiomax® (bivalirudin), Recothrom® Thrombin, topical (Recombinant), Cleviprex® (clevidipine butyrate) injectable emulsion and its ready-to-use formulation of Argatroban. Co. also has a pipeline of acute and intensive care hospital products in development, including cangrelor, oritavancin, MDCO-157 and IONSYS™ (fentanyl iontophoretic transdermal system), MDCO-216 and ALN-PCS02 and ALN-PCSsc of its ALN-PCS program. Co. also has a portfolio of 10 generic drugs, which it has the non-exclusive right to market in the U.S. Co. also co-promotes the oral tablet antiplatelet medicine BRILINTA® (ticagrelor) in the U.S.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 12,968 587,290 1,330,287
Total Sell Value $0 $432,876 $21,737,819 $44,493,835
Total People Sold 0 2 6 8
Total Sell Transactions 0 2 28 80
End Date 2014-04-27 2014-01-24 2013-07-26 2012-07-26

   
Records found: 493
  Page 1 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Kelly John C. Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 13,525     -
   Crouse William Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 34,439     -
   Kessler Armin M Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 122,874     -
   Spigelman Melvin K Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 34,439     -
   Savage Robert G Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 30,689     -
   Wyatt Elizabeth H S Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 34,439     -
   Shigeta Hiroaki Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 26,939     -
   Hugin Robert J Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 66,939     -
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2014-03-03 4 AS $30.31 $89,960 D/D (2,968) 29,312 -19%     
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2014-03-03 4 D $30.10 $43,402 D/D (1,442) 27,870     -
   Meanwell Clive Chairman & CEO   •       •      –    2014-03-03 4 D $30.10 $260,141 D/D (8,643) 318,304     -
   Furse Brent EVP, Chief Customer OfficerOff   •       –      –    2014-03-03 3 IO $0.00 $0 D/D 0 40,629 -18%     
   Kusiak Victoria EVP, Chief Integrity OfficerOf   •       –      –    2014-03-03 3 IO $0.00 $0 D/D 0 3,519 -18%     
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2014-03-03 4 D $29.99 $33,025 D/D (1,098) 31,080     -
   Heiman Cornelis EVP, Chief Innovation Officer   •       –      –    2014-03-03 4 A $0.00 $0 D/D 20,000 31,457     -
   Sblendorio Glenn President & CFO   •       •      –    2014-03-03 4 D $30.10 $106,820 D/D (3,549) 135,024     -
   Heiman Cornelis EVP, Chief Innovation OfficerO   •       –      –    2014-03-03 3 IO $0.00 $0 D/D 0 11,457 -18%     
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2014-03-01 4 A $0.00 $0 D/D 3,682 32,178     -
   Meanwell Clive Chairman & CEO   •       •      –    2014-03-01 4 A $0.00 $0 D/D 60,082 326,947     -
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2014-03-01 4 A $0.00 $0 D/D 10,504 32,280     -
   Sblendorio Glenn President & CFO   •       •      –    2014-03-01 4 A $0.00 $0 D/D 26,383 138,573     -
   Sblendorio Glenn President & CFO   •       •      –    2014-02-28 4 A $25.97 $10,180 D/D 392 112,190     -
   Meanwell Clive Chairman & CEO   •       •      –    2014-02-28 4 A $25.97 $10,180 D/D 392 266,865     -
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2014-02-25 4 D $30.49 $50,042 D/D (1,641) 28,496     -
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2014-02-25 4 D $30.49 $50,316 D/D (1,650) 21,776     -

  493 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed